Cranbrook Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cranbrook Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.6K	Hold	446	–	–	0.01%	185
2026 Q1	$57K	Hold	446	–	–	0.01%	189
2025 Q4	$54.4K	Hold	446	–	–	0.01%	200
2025 Q3	$44.7K	Sell	446 -130	-23%	-$11.7K	0.01%	211
2025 Q2	$47.8K	Hold	576	–	–	0.01%	200
2025 Q1	$46.7K	Hold	576	–	–	0.01%	190
2024 Q4	$51.9K	Sell	576 -201	-26%	-$19.5K	0.01%	187
2024 Q3	$76.8K	Hold	777	–	–	0.02%	163
2024 Q2	$72K	Hold	777	–	–	0.02%	164
2024 Q1	$73.7K	Hold	777	–	–	0.02%	141
2023 Q4	$69.4K	Hold	777	–	–	0.02%	143
2023 Q3	$56.7K	Hold	777	–	–	0.02%	142
2023 Q2	$64.6K	Hold	777	–	–	0.02%	140
2023 Q1	$59.2K	Hold	777	–	–	0.02%	143
2022 Q4	$64.5K	Hold	777	–	–	0.02%	141
2022 Q3	$62K	Hold	777	–	–	0.02%	155
2022 Q2	$58K	Hold	777	–	–	0.01%	160
2022 Q1	$70K	Hold	777	–	–	0.02%	155
2021 Q4	$87K	Hold	777	–	–	0.02%	144
2021 Q3	$98K	Hold	777	–	–	0.02%	136
2021 Q2	$105K	Hold	777	–	–	0.02%	129
2021 Q1	$105K	Hold	777	–	–	0.03%	130
2020 Q4	$109K	Buy	777 +414	+114%	+$53K	0.03%	122
2020 Q3	$40K	Hold	363	–	–	0.01%	152
2020 Q2	$41K	Hold	363	–	–	0.01%	149
2020 Q1	$28K	Buy	363 +162	+81%	+$14.3K	0.01%	150
2019 Q4	$19K	Sell	201 -158	-44%	-$13.7K	0.01%	181
2019 Q3	$27K	Hold	359	–	–	0.01%	160
2019 Q2	$31K	Hold	359	–	–	0.01%	155
2019 Q1	$33K	Hold	359	–	–	0.01%	152
2018 Q4	$26K	Buy	+359	New	+$28.9K	0.01%	155

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cranbrook Wealth Management's XBI Position: Q2 2026 in Review

Cranbrook Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 446 shares worth $70.6K. The position accounts for 0.01% of the portfolio, ranked #185.

Cranbrook Wealth Management first reported a position in XBI in Q4 2018 and has held it in 31 quarters since. The position peaked at $109K in Q4 2020. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cranbrook Wealth Management held 446 shares of State Street SPDR S&P Biotech ETF worth $70.6K as of Q2 2026.
Cranbrook Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Cranbrook Wealth Management's portfolio in Q2 2026, its #185 holding.
Cranbrook Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 31 quarters since.
Cranbrook Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $109K in Q4 2020.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Cranbrook Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.